Camilo Correa-Gallego
Overview
Explore the profile of Camilo Correa-Gallego including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Waller G, Khan T, Correa-Gallego C
Surg Clin North Am
. 2024 Nov;
105(1):15-30.
PMID: 39523070
The surgical management of gastric cancer has changed significantly from the first open partial gastrectomy in 1881 to contemporary minimally invasive approaches. The approach has shifted from open surgeries to...
2.
Khajoueinejad N, Sarfaty E, Yu A, Buseck A, Troob S, Imtiaz S, et al.
Ann Surg Oncol
. 2023 Dec;
31(4):2668-2678.
PMID: 38127214
Background: Frailty, a multidimensional state leading to reduced physiologic reserve, is associated with worse postoperative outcomes. Despite the availability of various frailty tools, surgeons often make subjective assessments of patients'...
3.
Birgin E, Hetjens S, Tam M, Correa-Gallego C, Rahbari N
Cancers (Basel)
. 2023 May;
15(8).
PMID: 37190258
SBRT is an emerging locoregional treatment modality for hepatocellular carcinoma (HCC). Although local tumor control rates seem encouraging, large-scale survival data comparing SBRT to surgical resection are lacking. We identified...
4.
Kaslow S, Hani L, Cohen S, Wolfgang C, Sacks G, Berman R, et al.
J Surg Oncol
. 2023 Apr;
128(2):262-270.
PMID: 37042430
Introduction: There is no consensus regarding the role of primary tumor resection for patients with metastatic pancreatic neuroendocrine tumors (panNET). We assessed surgical treatment patterns and evaluated the survival impact...
5.
Correa-Gallego C, Miyasaka Y, Hozaka Y, Nishino H, Kawamoto M, Vieira D, et al.
Pancreatology
. 2023 Mar;
23(3):258-265.
PMID: 36906508
Background: The ideal surveillance strategy after partial pancreatectomy for non-invasive IPMN remains undefined and existing guidelines provide conflicting recommendations. The present study was developed in anticipation of the joint meeting...
6.
Time to Curative-Intent Surgery in Gastric Cancer Shows a Bimodal Relationship with Overall Survival
Kaslow S, He Y, Sacks G, Berman R, Lee A, Correa-Gallego C
J Gastrointest Surg
. 2023 Jan;
27(5):855-865.
PMID: 36650415
Background: Time to treatment (TTT) varies widely for patients with gastric cancer. We aimed to evaluate relationships between time to treatment, overall survival (OS), and other surgical outcomes in patients...
7.
Kaslow S, Sacks G, Berman R, Lee A, Correa-Gallego C
Ann Surg
. 2022 Nov;
278(4):e798-e804.
PMID: 36353987
Objective: To evaluate long-term oncologic outcomes of patients with stage IV pancreatic ductal adenocarcinoma and to identify survival benchmarks for comparison when considering resection in these patients. Background: Highly selected...
8.
Kaslow S, Correa-Gallego C
Ann Surg Oncol
. 2022 Sep;
30(1):309-310.
PMID: 36167939
No abstract available.
9.
Kaslow S, Hani L, Sacks G, Lee A, Berman R, Correa-Gallego C
Ann Surg Oncol
. 2022 Sep;
30(1):300-308.
PMID: 36123415
Background: Adherence to evidence-based guidelines for gastric cancer is low, particularly at the hospital level, despite a strong association with improved overall survival (OS). We aimed to evaluate patterns of...
10.
Nohria A, Kaslow S, Hani L, He Y, Sacks G, Berman R, et al.
J Surg Res
. 2022 Jul;
279:304-311.
PMID: 35809355
Introduction: Surgery is an option for symptom palliation in patients with metastatic gastric cancer. Operative outcomes after palliative interventions are largely unknown. Herein, we assess the trends of surgical palliation...